4//SEC Filing
MCNAY JOSEPH C 4
Accession 0000914190-18-000401
CIK 0000707511other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 5:27 PM ET
Size
16.9 KB
Accession
0000914190-18-000401
Insider Transaction Report
Form 4
MCNAY JOSEPH C
Director
Transactions
- Conversion
Common Stock
2018-09-11$0.06/sh+2,089,120$125,347→ 6,001,842 total - Conversion
Convertible Promissory Note (right to buy)
2018-09-11−2,089,120→ 0 totalExercise: $0.06From: 2013-09-12Exp: 2018-09-11→ Common Stock (2,089,120 underlying)
Holdings
- 100,000
Stock Option (right to buy)
Exercise: $0.19Exp: 2022-02-11→ Common Stock (100,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying) Convertible Promissory Note (right to buy)
Exercise: $0.06From: 2014-01-07Exp: 2019-01-06→ Common Stock (416,667 underlying)- 120,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2021-03-25→ Common Stock (120,000 underlying) - 200,000
Stock Option (right to buy)
Exercise: $0.21Exp: 2028-07-17→ Common Stock (200,000 underlying)
Footnotes (6)
- [F1]The Convertible Promissory Note in the principal amount of $100,000 accrued $25,347.22 in interest and both principal and interest were converted into 2,089,120 shares of common stock at a conversion price of $0.06 per share.
- [F2]Represents the shares of common stock issuable upon conversion of the Convertible Promissory Note.
- [F3]100% vested.
- [F4]25,000 shares vest on each of 3/16/16, 3/16/17, 3/16/18 and 3/16/19.
- [F5]31,250 shares vest on each of 9/1/17, 9/1/18, 9/1/19 and 9/1/20.
- [F6]50,000 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
Documents
Issuer
REGENERX BIOPHARMACEUTICALS INC
CIK 0000707511
Entity typeother
Related Parties
1- filerCIK 0001257674
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 5:27 PM ET
- Size
- 16.9 KB